2

Percentage tumor necrosis following chemotherapy in neuroblastoma correlates with MYCN status but not survival

*Pediatric Hematology and Oncology* 2011; 28(2):106-114

Percentage tumor necrosis following chemotherapy in neuroblastoma correlates with MYCN status but not survival

*Pediatric Hematology and Oncology* 2011; 28(2):106-114

Adjuvant radiotherapy and/or chemotherapy after surgery for uterine carcinosarcoma

*Cochrane Database of Systematic Reviews* 2011; 1:CD006812

Melanoma sentinel node biopsy and prediction models for relapse and overall survival

*British Journal of Cancer* 2010; 103(8):1229-1236

Comparison of multimarker logistic regression models, with application to a genomewide scan of schizophrenia

*BMC Genetics* 2010; 11:80

Carotid sinus hypersensitivity: Disease state or clinical sign of ageing? Insights from a controlled study of autonomic function in symptomatic and asymptomatic subjects

*EP Europace* 2010; 12(11):1630-1636

Patterns of expression of DNA repair genes and relapse from melanoma

*Clinical Cancer Research* 2010; 16(21):5211-5221

A non-synonymous SNP within membrane metalloendopeptidase-like 1 (MMEL1) is associated with multiple sclerosis

*Genes and Immunity* 2010; 11(8):660-664

Variants near DMRT1, TERT and ATF7IP are associated with testicular germ cell cancer

*Nature Genetics* 2010; 42(7):604-607

Doxorubicin-induced suppression of poly(ADP-ribose) polymerase-1 (PARP-1) activity and expression and its implication for PARP inhibitors in clinical trials

*Cancer Chemotherapy and Pharmacology* 2010; 66(4):807-812